[1] Gabaldon-Perez A, Marcos-Garces V, Gavara J, et al.Coronary Revascularization and Long-Term Survivorship in Chronic Coronary Syndrome[J]. J Clin Med, 2021, 10(4):610.
[2] Heidenreich PA, Bozkurt B, Aguilar D, et al.2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. Circulation, 2022, 145(18):876-e894.
[3] 杨帆, 白抚生, 尤林, 等. 依达拉奉对脑缺血再灌注损伤患者神经功能、氧化应激和炎性反应的影响[J]. 疑难病杂志, 2020, 19(9):880-883-887.
[4] 李璇, 吴江, 杨朝慧, 等. MRA、3D-ASL及IVIM技术在短暂性脑缺血发作中的应用价值研究[J]. 磁共振成像, 2020, 11(5):321-325.
[5] 李建章. 慢性脑供血不足新思维[J]. 中国实用神经疾病杂志, 2007, 10(5):1-2.
[6] Knuuti J, Wijns W, Saraste A, et al.2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes[J]. Eur Heart J, 2020, 41(3):407-477.
[7] 中国医疗保健国际交流促进会急诊医学分会, 中华医学会急诊医学分会, 中国医师协会急诊医师分会, 等. 急性心力衰竭中国急诊管理指南(2022)[J]. 中国急救医学, 2022, 42(8):648-670.
[8] Han JK, Koo BK, Park KW, et al.Optimal intravascular ultrasound criteria for defining the functional significance of intermediate coronary stenosis: an international multicenter study. Cardiology, 2014, 127(4):256-262.
[9] Virani SS, Newby LK, Arnold SV, et al.2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation, 2023, 148(9):9-119.
[10] Heidenreich PA, Bozkurt B, Aguilar D, et al.2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. Circulation, 2022, 145(18):876-894.
[11] 程春红, 李鸿波, 黄炯. MRA、3D-ASL脑灌注成像技术诊断缺血性脑血管疾病的一致性比较[J]. 中国实验诊断学, 2020, 24(5):809-811.
[12] Deng H, Gao Y, Trappetti V, et al.Targeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damage[J]. Cell Mol Life Sci, 2022, 79(8):445.
[13] 王蓓丽, 李辉军, 伍严安, 等. 血清生化指标与冠心病患者冠状动脉狭窄程度的相关性[J]. 检验医学, 2020, 35(1):6-10.
[14] Hoiland RL, MacLeod DB, Stacey BS, et al. Hemoglobin and cerebral hypoxic vasodilation in humans: Evidence for nitric oxide-dependent and S-nitrosothiol mediated signal transduction[J]. J Cereb Blood Flow Metab, 2023, 43(9):1519-1531.
[15] 胡现宁, 袁涛, 刘武杰, 等. 急性缺血性卒中突出静脉征影响因素的研究现状[J].国际医学放射学杂志, 2021, 44(2):152-156.
[16] Chauin A.The Main Causes and Mechanisms of Increase in Cardiac Troponin Concentrations Other Than Acute Myocardial Infarction (Part 1): Physical Exertion, Inflammatory Heart Disease, Pulmonary Embolism, Renal Failure, Sepsis[J]. Vasc Health Risk Manag, 2021, 17:601-617.
[17] Pieske B, Wachter R, Shah SJ, et al.Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial[J]. JAMA, 2021, 326(19):1919-1929.
[18] 沈彬, 赵勇, 马军力, 等. 缺血后适应联合替罗非班干预急性ST段抬高型心肌梗死再灌注损伤的临床研究[J]. 中西医结合心脑血管病杂志, 2020, 18(9):1432-1435.
[19] Koklesova L, Mazurakova A, Samec M, et al.Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person[J]. EPMA J, 2021, 12(4):477-505.
[20] 杨阳, 贾万理, 晋婕. 血清sICAM-1、IMA、Hcy检测对AMI患者PCI术后心肌低灌注的预测价值[J]. 检验医学与临床, 2023, 20(3):303-305-309.
[21] 张卫东, 乔明刚.老年心衰并发心律失常患者血清Ang-2,Cys C水平及hs-CRP/PAB比值对临床预后评估的价值研究[J]. 现代检验医学杂志, 2021, 36(6):128-131-147. |
